FibriCheck receives perfect DTAC rating
FibriCheck is proud to announce that in addition to being among the first to go through Orcha’s rigorous assessment process, we are leading the charge in digital health standards compliance, as evidenced by the 100% rating received by the leading…
FibriCheck wins ‘Good health and well-being’ award at the WSA
We are proud to have won the award in the ‘Good health and well-being’ category at this year’s World Summit Awards. This award supports us as a pioneering Belgian digital health company in our mission to make technology a driver…
FibriCheck’s pulse beating stronger than ever in 2021
We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further accelerate the growth of both our business units. While keeping one eye on international growth, the FibriCheck app is also…
FibriCheck statement on Log4j vulnerability
FibriCheck is aware of the Log4j zero-day vulnerability in the Java logging framework. This vulnerability is being tracked as CVE-2021-442281/2 and currently has the highest severity score [10/10]. Therefore our technical team immediately started an internal investigation, on Saturday, December…
World Heart Rhythm Week: listening to your heart saves lives
Atrial fibrillation (AF) is the most common heart rhythm disorder. People as young as 40 have a 1 in 4 chance of developing AF in their lifetime, making them 5 times more likely to suffer a stroke. In an effort…
BeHRA and FibriCheck join forces for Heart Rhythm Week
On the occasion of Heart Rhythm Week, the Belgian Heart Rhythm Association (BeHRA) in association with FibriCheck is organising a nationwide campaign to raise awareness of remote heart rhythm monitoring for 10,000 people who are at risk.
FibriCheck brings TGA-certified heart health app to Australia
FibriCheck, the app capable of detecting heart rhythm disorders like atrial fibrillation, is now available in Australia for use with compatible smartphones (both iPhone and Android) as well as selected smartwatches. This means that the more than 500.000 Australians at…
Daiichi Sankyo and FibriCheck announce digital partnership set to transform at-home AF detection and diagnosis
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1 It is estimated that 300,000 people are living with undiagnosed AF and that over 2,000 lives could be saved every…
9 million euros in funding for eHealth pioneer Qompium
Hasselt, February 3, 2021 - Qompium, the pioneering Belgian digital health company, has received an additional 9 million euros in funding after a new capital round. With its business units FibriCheck (medical app which detects heart rhythm disorders) and Extra Horizon (secure,…
Safeguarding continuity of care in the UK during the pandemic
As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…